Abstract
Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanicolaou testing is critical, and interpretation of test results with knowledge of patient risk factors is imperative. Many evidence-based guidelines for screening, interpretation, and management have been developed and are widely available for use.
Original language | English (US) |
---|---|
Pages (from-to) | 131-149 |
Number of pages | 19 |
Journal | Primary Care - Clinics in Office Practice |
Volume | 36 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2009 |
Keywords
- Abnormal pap
- Cervical cancer
- Dysplasia
- Guidelines
- HPV
- Pap testing
- Screening
ASJC Scopus subject areas
- Pharmacology (medical)